• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带不同呈现方式的葡萄糖和半乳糖的 siRNA 缀合物的合成及体外抑制特性。

Synthesis and in vitro inhibition properties of siRNA conjugates carrying glucose and galactose with different presentations.

机构信息

Institute for Research in Biomedicine (IRB Barcelona), Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Networking Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Baldiri Reixac 10, 08028 Barcelona, Spain.

出版信息

Mol Divers. 2011 Aug;15(3):751-7. doi: 10.1007/s11030-011-9305-6. Epub 2011 Jan 26.

DOI:10.1007/s11030-011-9305-6
PMID:21267652
Abstract

Oligoribonucleotide conjugates and the corresponding siRNA duplexes against tumor necrosis factor carrying one, two, or four glucose and galactose residues at the 5'-end have been prepared using phosphoramidite chemistry. Carbohydrate-modified siRNA duplexes have similar inhibitory properties than unmodified RNA duplexes in HeLa cells transfected with oligofectamine. When HeLa cells were treated with siRNA carrying one, two, or four glucose residues without oligofectamine, no inhibition was observed. The inhibitory properties of siRNA carrying galactose residues without transfecting agent were tested on HuH-7 cells that have abundant asialoglycoprotein receptors. In these cells siRNA carrying galactose residues have slight anti-TNF inhibitory properties (25% in the best case) that are eliminated if the receptors are blocked with a competitor. These results demonstrate receptor-mediated uptake of siRNA carrying galactose residues, although the efficacy of the process is not enough for efficient RNA interference experiments.

摘要

已使用亚磷酰胺化学法制备了带有一个、两个或四个葡萄糖和半乳糖残基的寡核苷酸缀合物和相应的针对肿瘤坏死因子的 siRNA 双链体,在转染寡聚胺的 HeLa 细胞中,糖修饰的 siRNA 双链体与未修饰的 RNA 双链体具有相似的抑制特性。当 HeLa 细胞用不带寡聚胺的带有一个、两个或四个葡萄糖残基的 siRNA 处理时,没有观察到抑制作用。在具有丰富的去唾液酸糖蛋白受体的 HuH-7 细胞上测试了不带转染剂的带有半乳糖残基的 siRNA 的抑制特性。在这些细胞中,带有半乳糖残基的 siRNA 具有轻微的抗 TNF 抑制特性(在最佳情况下为 25%),如果用竞争物阻断受体,则该抑制特性被消除。这些结果表明,尽管该过程的功效不足以进行有效的 RNA 干扰实验,但带有半乳糖残基的 siRNA 可通过受体介导的摄取。

相似文献

1
Synthesis and in vitro inhibition properties of siRNA conjugates carrying glucose and galactose with different presentations.携带不同呈现方式的葡萄糖和半乳糖的 siRNA 缀合物的合成及体外抑制特性。
Mol Divers. 2011 Aug;15(3):751-7. doi: 10.1007/s11030-011-9305-6. Epub 2011 Jan 26.
2
Synthesis and in vitro inhibition properties of siRNA conjugates carrying acridine and quindoline moieties.带有吖啶和喹啉部分的 siRNA 缀合物的合成及体外抑制特性。
Chem Biodivers. 2012 Mar;9(3):557-66. doi: 10.1002/cbdv.201100321.
3
Synthesis, RNAi activity and nuclease-resistant properties of apolar carbohydrates siRNA conjugates.非极性糖核苷酸碱基对 RNAi 活性及核酸酶抗性的影响。
Bioorg Med Chem Lett. 2013 Jul 15;23(14):4048-51. doi: 10.1016/j.bmcl.2013.05.065. Epub 2013 May 28.
4
Preparation of Lipid-Conjugated siRNA Oligonucleotides for Enhanced Gene Inhibition in Mammalian Cells.脂质缀合的 siRNA 寡核苷酸的制备用于增强哺乳动物细胞中的基因抑制。
Methods Mol Biol. 2021;2282:119-136. doi: 10.1007/978-1-0716-1298-9_8.
5
Synthesis and properties of small interfering RNA duplexes carrying 5-ethyluridine residues.携带 5-乙基尿嘧啶核苷残基的小干扰 RNA 双链体的合成与性质。
Mol Divers. 2011 Aug;15(3):677-86. doi: 10.1007/s11030-010-9290-1. Epub 2010 Nov 16.
6
Stepwise synthesis of RNA conjugates carrying peptide sequences for RNA interference studies.用于RNA干扰研究的携带肽序列的RNA缀合物的逐步合成。
Mol Divers. 2009 Aug;13(3):287-93. doi: 10.1007/s11030-009-9110-7. Epub 2009 Feb 3.
7
Synthesis of lipid-oligonucleotide conjugates for RNA interference studies.脂质寡核苷酸缀合物的合成用于 RNA 干扰研究。
Chem Biodivers. 2011 Feb;8(2):287-99. doi: 10.1002/cbdv.201000274.
8
Synthesis of oligonucleotides carrying amino lipid groups at the 3'-end for RNA interference studies.合成在 3’-末端带有氨基脂质基团的寡核苷酸用于 RNA 干扰研究。
J Org Chem. 2010 Oct 15;75(20):6806-13. doi: 10.1021/jo101143j.
9
Building siRNAs with Cubes: Synthesis and Evaluation of Cubane-Modified siRNAs.用立方烷构建小干扰RNA:立方烷修饰的小干扰RNA的合成与评估
Chembiochem. 2021 Oct 13;22(20):2981-2985. doi: 10.1002/cbic.202100334. Epub 2021 Aug 11.
10
Simple solid-phase synthesis and biological properties of carbohydrate-oligonucleotide conjugates modified at the 3'-terminus.3'-末端修饰的糖-寡核苷酸缀合物的简单固相合成及生物学性质
Bioconjug Chem. 2010 Sep 15;21(9):1685-90. doi: 10.1021/bc100205v.

引用本文的文献

1
Beyond Lipids: Exploring Advances in Polymeric Gene Delivery in the Lipid Nanoparticles Era.超越脂质:探索脂质纳米颗粒时代中聚合物基因传递的新进展。
Adv Mater. 2024 Aug;36(31):e2404608. doi: 10.1002/adma.202404608. Epub 2024 Jun 19.
2
Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery.siRNA 生物缀合物在体外和体内递送上的当前方面。
Molecules. 2019 Jun 13;24(12):2211. doi: 10.3390/molecules24122211.
3
Novel Cluster and Monomer-Based GalNAc Structures Induce Effective Uptake of siRNAs in Vitro and in Vivo.

本文引用的文献

1
Synthesis, cell-surface binding, and cellular uptake of fluorescently labeled glucose-DNA conjugates with different carbohydrate presentation.荧光标记的葡萄糖-DNA 缀合物的合成、细胞表面结合和细胞摄取,具有不同的碳水化合物呈现方式。
Bioconjug Chem. 2010 Jul 21;21(7):1280-7. doi: 10.1021/bc100079n.
2
Synthesis and characterization of mannosylated oligoribonucleotides.甘露糖基寡核糖核苷酸的合成与表征。
Carbohydr Res. 2009 Nov 2;344(16):2137-43. doi: 10.1016/j.carres.2009.08.033. Epub 2009 Aug 31.
3
Recent developments in carbohydrate-decorated targeted drug/gene delivery.
新型簇状和单体型半乳糖胺结构可有效促进 siRNA 的体外和体内摄取。
Bioconjug Chem. 2018 Jul 18;29(7):2478-2488. doi: 10.1021/acs.bioconjchem.8b00365. Epub 2018 Jul 2.
4
Glucose-nucleobase pairs within DNA: impact of hydrophobicity, alternative linking unit and DNA polymerase nucleotide insertion studies.DNA中的葡萄糖-核碱基对:疏水性、替代连接单元的影响及DNA聚合酶核苷酸插入研究
Chem Sci. 2018 Mar 5;9(14):3544-3554. doi: 10.1039/c7sc04850e. eCollection 2018 Apr 14.
5
Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates.靶向信使核糖核酸和非编码核糖核酸的共价策略:关于小干扰核糖核酸、微小核糖核酸和抗微小核糖核酸缀合物的最新综述
Genes (Basel). 2018 Feb 6;9(2):74. doi: 10.3390/genes9020074.
6
Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.靶向肝脏疾病的治疗性寡核苷酸:转甲状腺素蛋白淀粉样变性
Molecules. 2015 Sep 30;20(10):17944-75. doi: 10.3390/molecules201017944.
糖基修饰的靶向药物/基因递药系统的最新进展
Med Res Rev. 2010 Mar;30(2):270-89. doi: 10.1002/med.20171.
4
Solid-phase synthesis of oligonucleotide conjugates useful for delivery and targeting of potential nucleic acid therapeutics.用于潜在核酸治疗药物递送和靶向的寡核苷酸缀合物的固相合成。
Bioconjug Chem. 2009 Jun;20(6):1065-94. doi: 10.1021/bc800406a.
5
Synthesis of mannose and galactose oligonucleotide conjugates by bi-click chemistry.通过双点击化学合成甘露糖和半乳糖寡核苷酸缀合物。
J Org Chem. 2009 Feb 6;74(3):1218-22. doi: 10.1021/jo802536q.
6
siRNA conjugate delivery systems.小干扰RNA缀合物递送系统
Bioconjug Chem. 2009 Jan;20(1):5-14. doi: 10.1021/bc800278e.
7
Experimental measurement of carbohydrate-aromatic stacking in water by using a dangling-ended DNA model system.利用悬垂末端DNA模型系统对水中碳水化合物-芳香族堆积进行实验测量。
Chemistry. 2008;14(26):7828-35. doi: 10.1002/chem.200800335.
8
Site-specific delivery of oligonucleotides to hepatocytes after systemic administration.全身给药后寡核苷酸向肝细胞的位点特异性递送。
Bioconjug Chem. 2008 Jan;19(1):290-8. doi: 10.1021/bc070126m. Epub 2007 Sep 13.
9
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.用于将小干扰RNA靶向体内递送至肝细胞的动态多聚缀合物。
Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):12982-7. doi: 10.1073/pnas.0703778104. Epub 2007 Jul 24.
10
Glycotargeting to improve cellular delivery efficiency of nucleic acids.糖基靶向以提高核酸的细胞递送效率。
Glycoconj J. 2007 Apr;24(2-3):107-23. doi: 10.1007/s10719-006-9023-y. Epub 2007 Feb 1.